<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04206371</url>
  </required_header>
  <id_info>
    <org_study_id>2019/08</org_study_id>
    <nct_id>NCT04206371</nct_id>
  </id_info>
  <brief_title>Defibrillation Testing During Implantable Cardioverter Defibrillator (ICD) Replacement</brief_title>
  <acronym>T-DEF</acronym>
  <official_title>Longitudinal Follow-up of Patients With Defibrillator Threshold Testing During Implantable Cardioverter Defibrillator (ICD) Replacement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CMC Ambroise Paré</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CMC Ambroise Paré</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate safety and clinical outcomes of a systematic defibrillation&#xD;
      threshold testing in patient with indication for defibrillator replacement.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Implantable cardioverter defibrillators (ICD) are strongly recommended in patients with left&#xD;
      ventricular systolic function ≤35% or selected patients with channelopathies and&#xD;
      cardiomyopathies.&#xD;
&#xD;
      Defibrillation threshold testing (DFT) defines the minimal energy required to successfully&#xD;
      terminate a ventricular arrhythmia by an ICD. It remains the gold standard to evaluate the&#xD;
      electrical integrity of the device. However inherent complications of this procedure have&#xD;
      been registered, such as refractory ventricular fibrillation, and the need for this practice&#xD;
      during implant and/or replacement of ICD has recently been questioned.&#xD;
&#xD;
      If several studies have led to abandonment of the DFT during initial ICD implant, its&#xD;
      interest during replacement is still controversial. Indeed, the leads essential for the&#xD;
      device electrical integrity are older, more fragile, and the ICD replacement may damage it.&#xD;
&#xD;
      Device replacement is indicated when battery reaches the point of Elective Replacement&#xD;
      Interval (ERI).&#xD;
&#xD;
      Patients over 18 years old with indication for replacement of defibrillator will be included.&#xD;
      Patient's informations (comorbidities, medical history and events during hospitalization or&#xD;
      follow-up) and device characteristics will be collected. Procedure will be realized under&#xD;
      local or general anesthesia and prophylactic antibiotic will be administrated. Leads will be&#xD;
      tested before and after the implantation of the new device. After connexion of the new&#xD;
      implanted device to the leads a DFT will be performed. Protocol of DFT will be decided by the&#xD;
      physician who will chose between induction of ventricular fibrillation or R-wave synchronized&#xD;
      shock. Patients will be followed for 6 and 12 months from the date of defibrillator&#xD;
      replacement.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 3, 2020</start_date>
  <completion_date type="Anticipated">February 3, 2023</completion_date>
  <primary_completion_date type="Anticipated">February 3, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of defibrillator electrical integrity dysfunction during generator replacement.</measure>
    <time_frame>4 hours</time_frame>
    <description>Abnormal shock impedance value.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of lead malfunction</measure>
    <time_frame>12 months</time_frame>
    <description>abnormal impedance value</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">330</enrollment>
  <condition>Implantable Cardioverter-Defibrillators</condition>
  <arm_group>
    <arm_group_label>Defibrillation testing during ICD replacment</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Defibrillator threshold testing</intervention_name>
    <description>Under general or local anesthesia. Induction of Ventricular Fibrillation or R-wave synchronized shock</description>
    <arm_group_label>Defibrillation testing during ICD replacment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with an ICD (VR or DR) or CRT-D undergoing generator replacement.&#xD;
&#xD;
          -  Consent for participation&#xD;
&#xD;
          -  Affiliation to the French social security system&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Atrial Fibrillation without effective anti-coagulation treatments.&#xD;
&#xD;
          -  Severe Aortic valve stenosis&#xD;
&#xD;
          -  Stroke occurred in the previous month&#xD;
&#xD;
          -  Hemodynamic instability contraindicating the high energy shock&#xD;
&#xD;
          -  Contraindication for anesthesia&#xD;
&#xD;
          -  Pregnant or breastfeeding women&#xD;
&#xD;
          -  Communication difficulties or neuropsychiatric disorder&#xD;
&#xD;
          -  Patients under protection of the adults (guardianship, curators or safeguard of&#xD;
             justice)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Caroline Grimard, MD</last_name>
    <phone>(+33) 01 46 41 50 23</phone>
    <email>grimard@inparys.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital Trousseau</name>
      <address>
        <city>Chambray-lès-Tours</city>
        <state>Centre-Val De Loire</state>
        <zip>37170</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu-CHU de Nancy-Hôpitaux de Brabois</name>
      <address>
        <city>Vandœuvre-lès-Nancy</city>
        <state>Grand Est</state>
        <zip>54500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>CMC Ambroise Paré</name>
      <address>
        <city>Neuilly-sur-Seine</city>
        <state>Ile-de-France</state>
        <zip>92200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU de Caen</name>
      <address>
        <city>Caen</city>
        <state>Normandie</state>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU de Toulouse-Hôpital Rangueil</name>
      <address>
        <city>Toulouse</city>
        <state>Occitanie</state>
        <zip>31400</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hôpital Privé du Confluent</name>
      <address>
        <city>Nantes,</city>
        <state>Pays De La Loire</state>
        <zip>44277</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Henri Duffaut</name>
      <address>
        <city>Avignon</city>
        <state>Provence-Alpes-Côte d'Azur</state>
        <zip>84902</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>December 18, 2019</study_first_submitted>
  <study_first_submitted_qc>December 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 20, 2019</study_first_posted>
  <last_update_submitted>May 4, 2021</last_update_submitted>
  <last_update_submitted_qc>May 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Defibrillation threshold testing</keyword>
  <keyword>Defibrillation lead</keyword>
  <keyword>Defibrillator replacement</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

